Feedback / Questions
PHST001 - Pheast Therap
https://www.businesswire.com/news/home/20250529856547/en/Pheast-Therapeutics-Receives-FDA-Fast-Track-Designation-for-PHST001-for-the-Treatment-of-Ovarian-Cancer
Jun 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next